WHO Grants Emergency Use Authorisation To Johnson & Johnson Vaccine

Johnson & Johnson Vaccine Under Review Over Fears Of Blood Clots

Johnson & Johnson Vaccine Under Review Over Fears Of Blood Clots

WHO Grants Emergency Use Authorisation To Johnson & Johnson Vaccine.

The World Health Organization (WHO) has today, Friday, March 12, issued emergency use authorisation for Johnson & Johnson’s coronavirus vaccine, paving the way for the one-shot dose to be used as part of the United Nation’s international vaccine distribution effort.

The greenlight from the WHO, which comes a day after the European Union approved the shot, means that countries that receive shots through the UN’s COVAX effort, which promotes equitable distribution of vaccines, could now quote the new endorsement. The vaccine provides fewer logistical hurdles than other shots given that it requires just one dose instead of two and does not need to be stored in ultra-cold temperatures like the Pfizer/BioNtech vaccine.

“Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” WHO Director-General Tedros Adhanom Ghebreyesus said in a statement. “But the hope offered by these tools will not materialize unless they are made available to all people in all countries.

“I urge governments and companies to live up to their commitments and to use all solutions at their disposal to ramp up production so that these tools become truly global public goods, available and affordable to all, and a shared solution to the global crisis,” he added.

WHO, in its statement announcing the approval, cited “ample data from large clinical trials” showing that the Johnson & Johnson shot was effective among adults. Studies have shown that the Johnson & Johnson vaccine is 66 per cent effective in protecting any cases of moderate to severe illness and 85 per cent effective against severe cases of COVID-19. It completely prevented hospitalizations and death four weeks after inoculation.

COVAX has already announced an initial deal with the pharmaceutical firm to obtain and distribute 500 million vaccine doses, though the arrangement is not legally binding. The WHO has also granted emergency use authorizations for vaccines from Oxford/AstraZeneca and Pfizer/BioNTech. COVAX is in the process of distributing doses of the Oxford/AstraZeneca vaccine and preparing to roll out doses of the Pfizer/BioNTech shot.

Thank you for taking the time to read this news article “WHO Grants Emergency Use Authorisation To Johnson & Johnson Vaccine”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

Author badge placeholder
Written by

Tony Winterburn

Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews